Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 24, 2013JAMA Internal Medicine

Responses of State Medicaid Programs to Buprenorphine Diversion

View Full Paper
Ask AI
Bookmark
Share

Authors

RCRobin E. ClarkCommunity HealthlinkJBJeffrey D. BaxterUniversity of Massachusetts Chan Medical School

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Clark et al. (2013) studied this question.

synapsesocial.com/papers/6a220205c7675eb28596ecd7https://doi.org/10.1001/jamainternmed.2013.9059
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Evidence Doesn’t Justify Steps By State Medicaid Programs To Restrict Opioid Addiction Treatment With Buprenorphine2011 · 85 citations
  2. 2Buprenorphine May Not Be as Safe as You Think: A Pediatric Fatality From Unintentional Exposure2012 · 47 citations
  3. 32011 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report2012 · 421 citations